Article
TRPM2 promotes the proliferation and invasion of pancreatic ductal adenocarcinoma
28 Mar 2018
Abstract excerpt
The aim of the present study was to investigate transient receptor potential cation channel subfamily M member 2 (TRPM2), a promising therapeutic target and biomarker for pancreatic ductal adenocarcinoma (PDAC) prognosis, in addition to determining its effects regarding tumor progression and invasion. PDAC is a fatal disease with a poor prognosis, and its associated pathogenic molecular mechanisms remain to be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
